Fall in uptake for funded mental health pharmacy training Exclusive: Half of the places on the University of Bradford's ‘Specialist mental health pharmacist training pathway’ for 2024/2025 have been filled.…
EMA finds no link between GLP-1 receptor agonists and suicidal thoughts The European Medicines Agency's Pharmacovigilance Risk Assessment Committee has confirmed that no update to product information is warranted.…
Pharmacy leaders ‘disappointed’ at cuts to free NHS mental health service NHS Practitioner Health, which provides support to NHS staff for mental health and addiction, will no longer offer services to secondary care staff.…
All forms of exercise effective in treating depression, meta-analysis finds Researchers concluded that exercise appeared to be equally effective for patients with different levels of depression.…
Lithium monitoring and toxicity management Pharmacists across sectors should be able to counsel patients on the recognition and prevention of lithium toxicity.…
RPS consults on advanced curricula for critical care and mental health pharmacy Once finalised, the two new curricula will be add-on modules to the Royal Pharmaceutical Society's core advanced pharmacist curriculum, published in June 2022.…
How to talk to patients about starting antidepressants Antidepressants are a treatment option for depression, but there are many misconceptions about them. This article summarises what pharmacists should discuss with patients starting treatment.…
PJ view: Training for specialist mental health pharmacists must be used — and quickly With training and resources on offer, trusts should be jumping at the chance to make the most of pharmacists’ specialist knowledge on mental health care teams.…
Test your knowledge on mental health An opportunity to test your knowledge on a range of mental health conditions and interventions.…
Widespread pharmacogenomic testing in psychiatry needs a stronger evidence base More research into the genomic factors influencing psychiatric medicines response is needed before widespread pharmacogenomic testing can be justified.…
